HIF1A and cancer: Therefore, in view of the core role of HIF-1α in the metabolic reprogramming of cancer cells (Song et al., 2020), which makes it an ideal target for cancer metabolic treatment, this study focuses on HIF-1α and attempts to intervene glycolysis of cancer cells by directly inhibiting its expression.